While everyone (here, at least) is talking about how Barack Obama “stuck it” to Israel, there were a few lines in his speech that must have unnerved the Islamic radicals. Like the man said – he plans to tell the truth to everyone who needs to hear it, and that includes things like rights for women in the Muslim world, fighting terrorism, and demanding an end to anti-Semitism, especially Holocaust denial. All three of these phenomena are (pardon the term) “sacred cows” for many Muslims (Holocaust denial goes far beyond Iran), and we should expect Obama to lean on Islamic countries and leaders for change in these areas, as much as he appears ready to lean on Israel to make a deal with Mahmoud Abbas and company.

So just how will this “leaning” take place? What could Obama do to convince anti-Israel and anti-Semitic states to change their ways, which have been set in centuries of tradition (long before there was a State of Israel)? He could start with the health situation in the Muslim world, and just how far behind Israel even the more advanced Muslim states, like Iran, really are. For example, Iranians are among the world’s biggest sufferers of diabetes – about one-third of adults in Tehran have disturbed glucose tolerance or diabetes, according to a 9500-person study last year, and the problem is prevalent throughout the country. Many Tehran residents are obese, and there is a history of both Type I (Juvenile) and Type II diabetes in many families.

Israel, on the other hand, is one of the world leaders in diabetes research, and Israeli research has contributed to a number of treatments used to combat diabetes in Iran. For example, Israel’s D-Cure program has been operating for several years, coordinating research efforts at Israel’s top institutions. “In many fields in diabetes research, Israel is leading the world – in looking for islet cells, and alternatives to beta cells,” said D-Cure president Prof. Itamar Raz, who is also president of the Israel Diabetes Association and head of the Diabetes Center at Hadassah University Medical Center in Jerusalem. Among the topics researched by D-Cure are cures and treatments related to both Type 1 and II diabetes. An Israeli innovation – the Oramed Insulin Capsule is an orally ingestible soft gel insulin capsule that the company believes will help Type II diabetics reduce the dependency on insulin shots and even prevent them from needing them at a later stage of the disease – is being tested now and will revolutionize treatment for Type II sufferers when approved.

And Israel’s Andromeda Biotech is about to embark on a phase III clinical trial of one of the most promising potential cures for Type I diabetes in the world, DiaPep 277, a synthetic peptide of 24 amino acids derived from the sequence of the human heat shock protein 60 (Hsp60). Heat shock protein therapies are considered among the best possibilities for a diabetes cure, and Iran has conducted its own research in these areas – often treading the ground broken by Israeli scientists! Interestingly, a link describing such research at an Iranian university has been taken down – fortunately, it’s available as  Google archive. Was it taken down because the Hsp60 research is so clearly connected to Israel?

This entry was posted on Friday, June 5th, 2009 at 11:07 am and is filed under development, health, hi-tech, israel, other stuff, security. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.